Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biocancell Therapeutics Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biocancell Therapeutics Inc. since year 2005.
Table 2 shows the detailed insider transactions of Biocancell Therapeutics Inc. since 2005.
The reporting company's ticker symbol is BICL.TA. The reporting company's CIK number is 1451980.
The total value of stock buying since 2005 is $400,235,960,628.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2012-07-31||Clal Biotechnology Industries Ltd.||Buy||10,731,726||.22||2,328,784|
|2009-07-06||Landsberg Moshe (Vice President of Technology)||Buy||7,143||.00||0|
|2008-07-31||Boim Aviv (Director)||Buy||800,463||500,000.00||400,231,500,000|
Insider trading activities including stock purchases, stock sales, and option exercises of BICL.TA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biocancell Therapeutics Inc. (symbol BICL.TA, CIK number 1451980) see the Securities and Exchange Commission (SEC) website.